Cargando…
Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843340/ https://www.ncbi.nlm.nih.gov/pubmed/36660673 http://dx.doi.org/10.21037/atm-2022-54 |
| _version_ | 1784870373470240768 |
|---|---|
| author | Scheen, André J. |
| author_facet | Scheen, André J. |
| author_sort | Scheen, André J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9843340 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98433402023-01-18 Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients Scheen, André J. Ann Transl Med Editorial Commentary AME Publishing Company 2022-12 /pmc/articles/PMC9843340/ /pubmed/36660673 http://dx.doi.org/10.21037/atm-2022-54 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Scheen, André J. Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients |
| title | Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients |
| title_full | Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients |
| title_fullStr | Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients |
| title_full_unstemmed | Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients |
| title_short | Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients |
| title_sort | does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between asian versus white patients |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843340/ https://www.ncbi.nlm.nih.gov/pubmed/36660673 http://dx.doi.org/10.21037/atm-2022-54 |
| work_keys_str_mv | AT scheenandrej doesraceethnicityinfluencetheimpactofnewglucoseloweringagentsoncardiovascularoutcomesacomparisonbetweenasianversuswhitepatients |